Management of High Blood Pressure in Preeclampsia
Blood pressure in preeclampsia requires urgent treatment in a monitored setting when severe (>160/110 mm Hg) using oral nifedipine or intravenous labetalol or hydralazine as first-line agents. 1
Diagnosis and Initial Assessment
- Preeclampsia is diagnosed by hypertension (BP ≥140/90 mmHg) after 20 weeks gestation with proteinuria (≥30 mg/mmol or 0.3 mg/mg protein/creatinine ratio) 1
- Initial assessment should include:
Management Algorithm for Hypertension in Preeclampsia
1. Severe Hypertension (>160/110 mmHg) - URGENT Treatment Required:
- First-line medications (in monitored setting): 1, 2
- IV labetalol: 20 mg IV bolus, then 40 mg 10 minutes later, 80 mg every 10 minutes for 2 additional doses to maximum 220 mg
- IV hydralazine: 5 mg IV bolus, then 10 mg every 20-30 minutes to maximum 25 mg
- Oral nifedipine: 10 mg PO, repeat every 20 minutes to maximum 30 mg
- Second-line agent (rarely, when others fail):
- Sodium nitroprusside: 0.25μg/kg/min to maximum 5μg/kg/min (caution: fetal cyanide poisoning risk if used >4 hours) 1
2. Non-Severe Hypertension (140-159/90-109 mmHg):
- Target diastolic BP of 85 mmHg (systolic 110-140 mmHg) 1
- First-line oral agents: 1, 2
- Methyldopa
- Labetalol
- Oxprenolol
- Nifedipine
- Second/third-line agents: hydralazine and prazosin 1
- Reduce or cease antihypertensives if diastolic BP falls <80 mmHg 1
Additional Management Measures
Seizure Prophylaxis:
- Magnesium sulfate for women with preeclampsia who have: 1, 2
- Proteinuria and severe hypertension
- Hypertension with neurological signs/symptoms
- Loading dose: 4-5g IV over 15-20 minutes
- Maintenance: 1-2g/hour continuous infusion 2
Maternal Monitoring:
- BP monitoring
- Repeated proteinuria assessment
- Clinical assessment including clonus
- Blood tests at least twice weekly: hemoglobin, platelets, liver and renal function, uric acid 1
- Monitor in high-dependency or intensive care setting for 24-48 hours for severe cases 2
Fetal Monitoring:
- Initial assessment to confirm fetal well-being
- In fetal growth restriction: serial fetal surveillance with ultrasound 1
- Serial evaluation of fetal growth every 2 weeks 2
- Corticosteroids for fetal lung maturation if <34 weeks pregnant 2
Delivery Considerations
Delivery is indicated for women with preeclampsia if: 1, 2
- Reached 37 weeks' gestation
- Repeated episodes of severe hypertension despite treatment with 3 classes of antihypertensives
- Progressive thrombocytopenia
- Progressively abnormal renal or liver enzyme tests
- Pulmonary edema
- Abnormal neurological features
- Non-reassuring fetal status
Postpartum Management
- Continue BP monitoring every 4-6 hours for at least 3 days 2
- Taper antihypertensive medications slowly after days 3-6 2
- Follow-up within 1 week if still on antihypertensives at discharge 2
- Review at 3 months postpartum 2
- Annual medical review recommended lifelong 2
Important Caveats
- Do not attempt to distinguish between "mild" and "severe" preeclampsia clinically, as all cases can rapidly progress to emergencies 2
- Do not discontinue close monitoring even if condition appears stable 2
- Volume expansion is not recommended routinely 2
- Do not delay delivery beyond 37 weeks in women with preeclampsia without severe features 2
- Preeclampsia rarely remits spontaneously and in most cases worsens with time 1
Remember that preeclampsia is more than just hypertension—it's a multisystem disorder that requires comprehensive management to prevent maternal and fetal complications.